| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2754745 | Clinical Lymphoma Myeloma and Leukemia | 2015 | 28 Pages |
Abstract
Low TRIM62 levels, consistent with a tumor suppressor role, represent an independent adverse prognostic factor in AML.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Alfonso Quintás-Cardama, Nianxiang Zhang, Yi Hua Qiu, Sean Post, Chad J. Creighton, Jorge Cortes, Kevin R. Coombes, Steven M. Kornblau,